Celon Pharma SA
WSE:CLN

Watchlist Manager

Celon Pharma SA

WSE:CLN

Watchlist

Dividends

Discount Rate

Price: 26.6 PLN 2.31% Market Closed

Market Cap: 1.4B PLN

Have any thoughts about
Celon Pharma SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 26.6 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

CLN Alert

Celon Pharma SA

26.6

+0.6 (+2.31%)

52 Week Range	14.1 32.3
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Celon Pharma SA

What unique competitive advantages
does Celon Pharma SA hold over its rivals?

What risks and challenges
does Celon Pharma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Celon Pharma SA.

What unique competitive advantages
does Celon Pharma SA hold over its rivals?

What risks and challenges
does Celon Pharma SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Celon Pharma SA.

Provide P/S
for Celon Pharma SA.

Provide P/E
for Celon Pharma SA.

Provide P/OCF
for Celon Pharma SA.

Provide P/FCFE
for Celon Pharma SA.

Provide P/B
for Celon Pharma SA.

Provide EV/S
for Celon Pharma SA.

Provide EV/GP
for Celon Pharma SA.

Provide EV/EBITDA
for Celon Pharma SA.

Provide EV/EBIT
for Celon Pharma SA.

Provide EV/OCF
for Celon Pharma SA.

Provide EV/FCFF
for Celon Pharma SA.

Provide EV/IC
for Celon Pharma SA.

Show me price targets
for Celon Pharma SA made by professional analysts.

What are the Revenue projections
for Celon Pharma SA?

How accurate were the past Revenue estimates
for Celon Pharma SA?

What are the Net Income projections
for Celon Pharma SA?

How accurate were the past Net Income estimates
for Celon Pharma SA?

What are the EPS projections
for Celon Pharma SA?

How accurate were the past EPS estimates
for Celon Pharma SA?

What are the EBIT projections
for Celon Pharma SA?

How accurate were the past EBIT estimates
for Celon Pharma SA?

Compare the revenue forecasts
for Celon Pharma SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Celon Pharma SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Celon Pharma SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Celon Pharma SA compared to its peers.

Compare the P/E ratios
of Celon Pharma SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Celon Pharma SA with its peers.

Analyze the financial leverage
of Celon Pharma SA compared to its main competitors.

Show all profitability ratios
for Celon Pharma SA.

Provide ROE
for Celon Pharma SA.

Provide ROA
for Celon Pharma SA.

Provide ROIC
for Celon Pharma SA.

Provide ROCE
for Celon Pharma SA.

Provide Gross Margin
for Celon Pharma SA.

Provide Operating Margin
for Celon Pharma SA.

Provide Net Margin
for Celon Pharma SA.

Provide FCF Margin
for Celon Pharma SA.

Show all solvency ratios
for Celon Pharma SA.

Provide D/E Ratio
for Celon Pharma SA.

Provide D/A Ratio
for Celon Pharma SA.

Provide Interest Coverage Ratio
for Celon Pharma SA.

Provide Altman Z-Score Ratio
for Celon Pharma SA.

Provide Quick Ratio
for Celon Pharma SA.

Provide Current Ratio
for Celon Pharma SA.

Provide Cash Ratio
for Celon Pharma SA.

What is the historical Revenue growth
over the last 5 years for Celon Pharma SA?

What is the historical Net Income growth
over the last 5 years for Celon Pharma SA?

What is the current Free Cash Flow
of Celon Pharma SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Celon Pharma SA.

Section:

Wall Street
Price Targets

CLN Price Targets Summary
Celon Pharma SA

Wall Street analysts forecast CLN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLN is 23.56 PLN with a low forecast of 12.12 PLN and a high forecast of 40.95 PLN.

Lowest

Price Target

12.12 PLN

54% Downside

Average

Price Target

23.56 PLN

11% Downside

Highest

Price Target

40.95 PLN

54% Upside

Celon Pharma SA Competitors:
Price Targets

VY4

SNDL Inc

76% Upside

SUPRIYA

Supriya Lifescience Ltd

28% Downside

DERM

Journey Medical Corp

90% Upside

ASRT

Assertio Holdings Inc

229% Upside

VY4

SNDL Inc

76% Upside

SUPRIYA

Supriya Lifescience Ltd

28% Downside

DERM

Journey Medical Corp

90% Upside

ASRT

Assertio Holdings Inc

229% Upside

3613

Beijing Tong Ren Tang Chinese Medicine Co Ltd

57% Upside

002422

Sichuan Kelun Pharmaceutical Co Ltd

41% Upside

170900

Dong-A ST Co Ltd

46% Upside

4528

Ono Pharmaceutical Co Ltd

25% Upside

Revenue
Forecast

Revenue Estimate
Celon Pharma SA

For the last 7 years the compound annual growth rate for Celon Pharma SA's revenue is 8%. The projected CAGR for the next 3 years is 5%.

Past Growth

Estimated Growth

Estimates Accuracy

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Celon Pharma SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

23%

Average Beat

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Celon Pharma SA

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

Average Beat

What are analyst estimates?

What is CLN's stock price target?

Price Target
23.56 PLN

According to Wall Street analysts, the average 1-year price target for CLN is 23.56 PLN with a low forecast of 12.12 PLN and a high forecast of 40.95 PLN.

What is Celon Pharma SA's Revenue forecast?

Projected CAGR
5%

For the last 7 years the compound annual growth rate for Celon Pharma SA's revenue is 8%. The projected CAGR for the next 3 years is 5%.

Celon Pharma SA
WSE:CLN

Wall Street
Price Targets

CLN Price Targets Summary
Celon Pharma SA

Revenue
Forecast

Revenue Estimate
Celon Pharma SA

Operating Income
Forecast

Operating Income Estimate
Celon Pharma SA

Net Income
Forecast

Net Income Estimate
Celon Pharma SA

See Also

What is CLN's stock price target?

Price Target
23.56 PLN

What is Celon Pharma SA's Revenue forecast?

Projected CAGR
5%

Company

Help

Tools

Stocks

Celon Pharma SA WSE:CLN

Wall Street Price Targets

CLN Price Targets Summary Celon Pharma SA

Revenue Forecast

Revenue Estimate Celon Pharma SA

Operating Income Forecast

Operating Income Estimate Celon Pharma SA

Net Income Forecast

Net Income Estimate Celon Pharma SA

See Also

What is CLN's stock price target? Price Target 23.56 PLN

What is Celon Pharma SA's Revenue forecast? Projected CAGR 5%

Company

Help

Tools

Stocks

Celon Pharma SA
WSE:CLN

Wall Street
Price Targets

CLN Price Targets Summary
Celon Pharma SA

Revenue
Forecast

Revenue Estimate
Celon Pharma SA

Operating Income
Forecast

Operating Income Estimate
Celon Pharma SA

Net Income
Forecast

Net Income Estimate
Celon Pharma SA

What is CLN's stock price target?

Price Target
23.56 PLN

What is Celon Pharma SA's Revenue forecast?

Projected CAGR
5%